Results 151 to 160 of about 5,801,283 (182)

Acarboxy Prothrombin (PIVKA-II) as a Marker of Hepatoblastoma in Infants

Journal of Pediatric Gastroenterology and Nutrition, 1987
SummaryWe evaluated plasma PIVKA‐II (protein induced by vitamin K absence or antagonist‐II, acarboxy prothrombin) levels in three infants with hepatoblastoma as a tumor marker. PIVKA‐II levels were highly elevated in all three patients. Vitamin K administration, performed in two patients, resulted in only moderate reduction of PIVKA‐II levels ...
K, Motohara, F, Endo, I, Matsuda, T, Iwamasa   +3 more
openaire   +2 more sources

One Case of Abnormal Elevation of PIVKA-II

Clinical Laboratory
Protein Induced by Vitamin K Absence or Antagonist II (PIVKA-II) is a serum biomarker that is specifically elevated in hepatocellular carcinoma (HCC) and has important value in early diagnosis, prognosis evaluation, and recurrence prediction of liver cancer.We report a case of extreme elevation of serum PIVKA-II due to the use of warfarin.The patient's
Gangfeng, Li, Tao, Lu, Qiong, Wang
openaire   +2 more sources

Immunolocalisation of PIVKA-II in paraffin-embedded specimens of hepatocellular carcinoma

Liver, 1999
Abstract: Aims/Background: Although serum PIVKA‐II has been widely used as a tumor marker for hepatocellular carcinoma (HCC), little information is available concerning tissue PIVKA‐II, and detection of tissue PIVKA‐II in paraffin‐embedded tissue specimens of HCC is also considered difficult. Methods: Paraffin‐embedded HCC tissues obtained at autopsy
Masaya Tamano, Hitoshi Sugaya, Akira Terano   +2 more
exaly   +3 more sources

IS PIVKA-II A PROMISING BIOMARKER FOR HEPATOCELLULAR CARCINOMA?

2020
Astrakhan Medical Journal, Volume 15, Issue 1, 2020, Pages 6 ...
Broz, Pavel, Svobodova, Sarka, Karlíkova, Marie, Topolcan, Ondrej, Treska, Vladislav, Kucera, Radek   +5 more
openaire   +1 more source

Synthesis And Catabolism Of Human Prothrombin And Pivka-II

Thrombosis and Haemostasis, 1981
The synthesis and catabolism of both prothrombin and PIVKA-II were studied in patients with stable stage of various thromboembolic disorders. Laboratory examinations revealed that their hemostatic and fibrinolytic activities were within normal range.
H Tsukada, M R Takada, H Tanaka, T Takeuchi, H Gonmori, N Kobayashi, T Maekawa   +6 more
openaire   +1 more source

Hepatocellular carcinoma: PIVKA-II may be unsuitable for Indian patients

Laboratory Medicine
Abstract Introduction Hepatocellular carcinoma (HCC) diagnosis requires a combination of elevated ɑ-fetoprotein (AFP) levels and liver imaging. We evaluated the role of prothrombin induced by vitamin K antagonist-II (PIVKA-II) in patients with suspected HCC.
Dinesh Jothimani, Sathish Srinivasan, Evangeline Simon, Lexmi Priya Raju, Hemalatha Ramachandran, Abraham Sam Rajan, Komalavalli Subbiah, Mukul Vij, Mohamed Rela   +8 more
openaire   +2 more sources

Plasma PIVKA-II levels in epileptic patients

Brain and Development, 1990
Y, Origuchi, K, Motohara, F, Endo, I, Matsuda   +3 more
openaire   +2 more sources

[Increased serum PIVKA-II levels in hyperthyroidism].

Rinsho byori. The Japanese journal of clinical pathology, 2002
PIVKA-II has been practically used as a tumor marker of hepatocellular carcinoma. On the other hand, increased serum PIVKA-II concentration was reported in a Japanese patient who had hyperthyroidism without liver diseases. To evaluate whether thyroid hormone is related with serum PIVKA-II, we examined serum PIVKA-II concentrations in patients with ...
M, Morimoto, K, Takeda, E, Ohara, Y, Nishimori, T, Hisahara, M, Nishida, T, Sugiura   +6 more
openaire   +1 more source

People also looked at

Frontiers in Public Health, 2022
Naibin Yang, Shanshan Li, Mingqin Lu
exaly  

4780410 Sandwich enzyme immunoassay for PIVKA-II with monoclonal anti-PIVKA-II antibody

Biotechnology Advances, 1989
openaire   +1 more source